Objectives Elevated resting heart rate (RHR) predicts mortality in middle-aged and older adults, primarily through ...

is an open access journal by BMJ and BCS, publishing original research in cardiovascular medicine. Open Heart considers submissions of a variety of article types, including original research articles, ...

Background The reported prevalence and burden of coronary artery disease in young adults varies markedly in published studies ...

Background Invasive procedures, including endomyocardial biopsy (EMB), right heart catheterisation (RHC) and coronary ...

Background C-reactive protein (CRP) is commonly used to assess systemic inflammation, yet its prognostic value in acute ...

Background Rheumatic heart disease (RHD) remains a major cause of morbidity and mortality in low-resource settings, ...

Objective Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiomyopathy characterised by pathological left ...

This study aimed to explore whether baseline values and 12-month change in the 6-Minute Walk Distance (6MWD) and the physical ...

Original research: Operational performance of the 2023 World Heart Federation screening criteria for rheumatic heart disease in a high-risk, resource-limited population (8 July, 2026) ...

Background Pulmonary hypertension (PH) medical therapies are commonly used as a bridge to balloon pulmonary angioplasty (BPA) in patients with chronic thromboembolic PH (CTEPH) but their effectiveness ...

Background Patients with angina and no obstructive coronary artery disease (ANOCA) frequently receive empirical antianginal therapy that fails to target underlying pathophysiological mechanisms.

Introduction The clinical management of Obstructive Hypertrophic Cardiomyopathy remains challenging, and the phase III EXPLORER-HCM trial has demonstrated that the novel cardiac myosin inhibitor ...